Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-200
Closed -$7K 2298
2022
Q2
$7K Buy
200
+150
+300% +$7.25K ﹤0.01% 2085
2022
Q1
$3K Buy
+50
New +$3.16K ﹤0.01% 2468
2021
Q3
Sell
-58
Closed -$5K 2866
2021
Q2
$5K Hold
58
﹤0.01% 2445
2021
Q1
$6K Hold
58
﹤0.01% 2595
2020
Q4
$6K Buy
+58
New +$4.72K ﹤0.01% 2420
2020
Q2
Sell
-100
Closed -$4K 2592
2020
Q1
$4K Hold
100
﹤0.01% 2103
2019
Q4
$5K Hold
100
﹤0.01% 2184
2019
Q3
$6K Hold
100
﹤0.01% 2057
2019
Q2
$9K Sell
100
-15
-13% -$1.52K ﹤0.01% 1937
2019
Q1
$13K Sell
115
-340
-75% -$36.2K ﹤0.01% 1743
2018
Q4
$37K Buy
455
+200
+78% +$18.1K ﹤0.01% 1232
2018
Q3
$28K Buy
255
+160
+168% +$15.1K ﹤0.01% 1436
2018
Q2
$7K Sell
95
-140
-60% -$9.3K ﹤0.01% 1830
2018
Q1
$15K Sell
235
-585
-71% -$44K ﹤0.01% 1505
2017
Q4
$62K Buy
820
+450
+122% +$32.4K 0.01% 918
2017
Q3
$28K Sell
370
-21
-5% -$1.92K ﹤0.01% 1197
2017
Q2
$32K Buy
+391
New +$33.7K ﹤0.01% 1099

Other funds holding IRBT

Geneos Wealth Management's IRBT Position: Q3 2022 in Review

Geneos Wealth Management sold out of iRobot (IRBT) in Q3 2022, closing a stake of 200 shares — an estimated $7K sold.

Geneos Wealth Management first reported a position in IRBT in Q2 2017 and held it in 17 quarters. The position peaked at $62K in Q4 2017. 245 funds tracked by Wall St. Rank hold IRBT as of Q3 2022.

  • Geneos Wealth Management reported no remaining iRobot position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 200 iRobot shares in Q3 2022, an estimated $7K.
  • Geneos Wealth Management first reported a position in iRobot in Q2 2017 and held it in 17 quarters.
  • Geneos Wealth Management's iRobot position peaked at $62K in Q4 2017.
  • 245 funds tracked by Wall St. Rank held iRobot as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.